on ABIVAX (EPA:ABVX)
ABIVAX: Information on share capital and voting rights as of August 31, 2026
On September 25, 2026, ABIVAX released information regarding its share capital and voting rights. The company, listed on Euronext Paris, has a share capital of €873,500.47. As of August 31, 2026, the number of shares comprising the share capital stood at 87,271,525.
ABIVAX has 88,526,782 theoretical and exercisable voting rights. The theoretical rights are used for crossing thresholds, including shares without voting rights. Exercisable rights exclude these shares, following a 2007 recommendation from the AMF (French Financial Markets Authority), to provide clear information to investors.
This data highlights the company's regulatory transparency in financial governance.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news